Psych101, iv started a board based "research" on biotechs generally to firstly assist with picking "winners" and secondly to try and get some rule on thumb measure as to when the retail market considered it safer to take a position or more importantly when the big pharmas decide the biotech company is Worth bidding for.
The influencing factors seem to many and varied to make a formula but PTX cirtainly ticks many of the "mandatory" requirements. Some are 1) FDA approval for human trials, 2) nature of illness requiring treatement, ie scale, history of other treatments, 3) at least at phase 2 testing, 4) more than 1 trial in the pipeline, 5) completion or leading edge, and there are obviously many more.
PTX ticks all the above box's or soon will. 1)FDA aproval for 4 products, 2) high unmet treatment need worth billions, 3) one product/trial in phase 2 and two products following close behind, 4) four products in trials 5) PTX trials are significantly more advanced that any other company developing comparable products.
It's fair to assume interest will increase exponentially from here on in.
PTX Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held
